{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T05:12:04Z","timestamp":1773551524700,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00066-023-02106-5","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T10:01:42Z","timestamp":1688983302000},"page":"982-991","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy"],"prefix":"10.1007","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9619-1427","authenticated-orcid":false,"given":"S.","family":"Lautenschlaeger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dumke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Exeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hauswald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Engenhart-Cabillic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"issue":"4","key":"2106_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.21037\/jgo.2017.03.04","volume":"8","author":"PJ Boimel","year":"2017","unstructured":"Boimel\u00a0PJ, Berman\u00a0AT, Li\u00a0J, Apisarnthanarax\u00a0S, Both\u00a0S, Lelionis\u00a0K, Larson\u00a0GL, Teitelbaum\u00a0U, Lukens\u00a0JN, Ben-Josef\u00a0E, Metz\u00a0JM, Plastaras\u00a0JP (2017) Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma. J\u00a0Gastrointest Oncol 8(4):665\u2013674","journal-title":"J Gastrointest Oncol"},{"issue":"9","key":"2106_CR2","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/annonc\/mdn281","volume":"19","author":"B Chauffert","year":"2008","unstructured":"Chauffert\u00a0B, Mornex\u00a0F, Bonnetain\u00a0F, Rougier\u00a0P, Mariette\u00a0C, Bouch\u00e9\u00a0O, Bosset\u00a0JF, Aparicio\u00a0T, Mineur\u00a0L, Azzedine\u00a0A, Hammel\u00a0P, Butel\u00a0J, Stremsdoerfer\u00a0N, Maingon\u00a0P, Bedenne\u00a0L (2008) Phase\u00a0III trial comparing intensive induction chemoradiotherapy (60\u202fGy, infusional 5\u2011FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD\/SFRO study. Ann Oncol 19(9):1592\u20131599","journal-title":"Ann Oncol"},{"issue":"4","key":"2106_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ejso.2016.12.012","volume":"43","author":"T Comito","year":"2017","unstructured":"Comito\u00a0T, Cozzi\u00a0L, Zerbi\u00a0A, Franzese\u00a0C, Clerici\u00a0E, Tozzi\u00a0A, Iftode\u00a0C, Navarria\u00a0P, D\u2019Agostino\u00a0G, Fogliata\u00a0A, Mancosu\u00a0P, Tomatis\u00a0S, Carnaghi\u00a0C, Personeni\u00a0N, Santoro\u00a0A, Scorsetti\u00a0M (2017) Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. Eur J Surg Oncol 43(4):735\u2013742","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"2106_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.7150\/jca.13295","volume":"7","author":"N Dagoglu","year":"2016","unstructured":"Dagoglu\u00a0N, Callery\u00a0M, Moser\u00a0J, Tseng\u00a0J, Kent\u00a0T, Bullock\u00a0A, Miksad\u00a0R, Mancias\u00a0JD, Mahadevan\u00a0A (2016) Stereotactic body radiotherapy (SBRT) reirradiation for recurrent pancreas cancer. J\u00a0Cancer 7(3):283\u2013288","journal-title":"J Cancer"},{"issue":"16_suppl","key":"2106_CR5","first-page":"4008","volume":"40","author":"R Fietkau","year":"2022","unstructured":"Fietkau\u00a0R, Ghadimi\u00a0M, Gr\u00fctzmann\u00a0R, Wittel\u00a0UA, Jacobasch\u00a0L, Uhl\u00a0W, Croner\u00a0RS, Bechstein\u00a0WO, Neumann\u00a0UP, Waldschmidt\u00a0D, Boeck\u00a0SH, Moosmann\u00a0N, Reinacher-Schick\u00a0AC, Golcher\u00a0H, Adler\u00a0W, Semrau\u00a0S, Kallies\u00a0A, Hecht\u00a0M, Tannapfel\u00a0A, Oettle\u00a0H (2022) Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: First results of the CONKO-007 trial. JCO Clin Cancer Inform 40(16_suppl):4008","journal-title":"JCO Clin. Cancer Inform."},{"issue":"1","key":"2106_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00066-020-01680-2","volume":"197","author":"R Fietkau","year":"2021","unstructured":"Fietkau\u00a0R, Gr\u00fctzmann\u00a0R, Wittel\u00a0UA, Croner\u00a0RS, Jacobasch\u00a0L, Neumann\u00a0UP, Reinacher-Schick\u00a0A, Imhoff\u00a0D, Boeck\u00a0S, Keilholz\u00a0L, Oettle\u00a0H, Hohenberger\u00a0WM, Golcher\u00a0H, Bechstein\u00a0WO, Uhl\u00a0W, Pirkl\u00a0A, Adler\u00a0W, Semrau\u00a0S, Rutzner\u00a0S, Ghadimi\u00a0M, Lubgan\u00a0D (2021) R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007\u00b1 trial. Strahlenther Onkol 197(1):8\u201318","journal-title":"Strahlenther Onkol"},{"key":"2106_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1748-717X-8-27","volume":"8","author":"D Habermehl","year":"2013","unstructured":"Habermehl\u00a0D, Brecht\u00a0IC, Bergmann\u00a0F, Welzel\u00a0T, Rieken\u00a0S, Werner\u00a0J, Schirmacher\u00a0P, B\u00fcchler\u00a0MW, Debus\u00a0J, Combs\u00a0SE (2013) Chemoradiation in patients with isolated recurrent pancreatic cancer\u2014therapeutical efficacy and probability of re-resection. Radiat Oncol 8:27","journal-title":"Radiat Oncol"},{"issue":"17","key":"2106_CR8","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1001\/jama.2016.4324","volume":"315","author":"P Hammel","year":"2016","unstructured":"Hammel\u00a0P, Huguet\u00a0F, van Laethem\u00a0J\u2011L, Goldstein\u00a0D, Glimelius\u00a0B, Artru\u00a0P, Borbath\u00a0I, Bouch\u00e9\u00a0O, Shannon\u00a0J, Andr\u00e9\u00a0T, Mineur\u00a0L, Chibaudel\u00a0B, Bonnetain\u00a0F, Louvet\u00a0C (2016) Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of Gemcitabine with or without Erlotinib: the LAP07 randomized clinical trial. JAMA 315(17):1844\u20131853","journal-title":"JAMA"},{"key":"2106_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.radonc.2019.03.012","volume":"136","author":"Y Hiroshima","year":"2019","unstructured":"Hiroshima\u00a0Y, Fukumitsu\u00a0N, Saito\u00a0T, Numajiri\u00a0H, Murofushi\u00a0KN, Ohnishi\u00a0K, Nonaka\u00a0T, Ishikawa\u00a0H, Okumura\u00a0T, Sakurai\u00a0H (2019) Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer. Radiother Oncol 136:37\u201343","journal-title":"Radiother Oncol"},{"issue":"2","key":"2106_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2011.05.038","volume":"99","author":"J Huang","year":"2011","unstructured":"Huang\u00a0J, Robertson\u00a0JM, Margolis\u00a0J, Balaraman\u00a0S, Gustafson\u00a0G, Khilanani\u00a0P, Nadeau\u00a0L, Jury\u00a0R, McIntosh\u00a0B (2011) Long-term results of full-dose gemcitabine with radiation therapy compared to 5\u2011fluorouracil with radiation therapy for locally advanced pancreas cancer. Radiother Oncol 99(2):114\u2013119","journal-title":"Radiother Oncol"},{"issue":"3","key":"2106_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.adro.2018.04.003","volume":"3","author":"KR Jethwa","year":"2018","unstructured":"Jethwa\u00a0KR, Tryggestad\u00a0EJ, Whitaker\u00a0TJ, Giffey\u00a0BT, Kazemba\u00a0BD, Neben-Wittich\u00a0MA, Merrell\u00a0KW, Haddock\u00a0MG, Hallemeier\u00a0CL (2018) Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomes. Adv Radiat Oncol 3(3):314\u2013321","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"2106_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.radonc.2018.02.003","volume":"129","author":"S Kawashiro","year":"2018","unstructured":"Kawashiro\u00a0S, Yamada\u00a0S, Isozaki\u00a0Y, Nemoto\u00a0K, Tsuji\u00a0H, Kamada\u00a0T (2018) Carbon-ion radiotherapy for locoregional recurrence after primary surgery for pancreatic cancer. Radiother Oncol 129(1):101\u2013104","journal-title":"Radiother Oncol"},{"key":"2106_CR13","doi-asserted-by":"publisher","first-page":"153303381878387","DOI":"10.1177\/1533033818783879","volume":"17","author":"TH Kim","year":"2018","unstructured":"Kim\u00a0TH, Lee\u00a0WJ, Woo\u00a0SM, Kim\u00a0H, Oh\u00a0ES, Lee\u00a0JH, Han\u00a0S\u2011S, Park\u00a0S\u2011J, Suh\u00a0Y\u2011G, Moon\u00a0SH, Kim\u00a0SS, Kim\u00a0DY (2018) Effectiveness and safety of simultaneous integrated boost-proton beam therapy for localized pancreatic cancer. Technol Cancer Res Treat 17:1533033818783879","journal-title":"Technol Cancer Res Treat"},{"issue":"6","key":"2106_CR14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.acra.2018.07.025","volume":"26","author":"JD Kova\u010d","year":"2019","unstructured":"Kova\u010d\u00a0JD, Mayer\u00a0P, Hackert\u00a0T, Klauss\u00a0M (2019) The time to and type of pancreatic cancer recurrence after surgical resection: is prediction possible? Acad Radiol 26(6):775\u2013781","journal-title":"Acad Radiol"},{"issue":"4","key":"2106_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s00066-021-01827-9","volume":"198","author":"J Liermann","year":"2022","unstructured":"Liermann\u00a0J, Ben-Josef\u00a0E, Syed\u00a0M, Debus\u00a0J, Herfarth\u00a0K, Naumann\u00a0P (2022) Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer. Strahlenther Onkol 198(4):378\u2013387","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"2106_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijrobp.2013.06.817","volume":"87","author":"JN Lukens","year":"2013","unstructured":"Lukens\u00a0JN, Mick\u00a0R, Demas\u00a0KL, Apisarnthanarax\u00a0S, Metz\u00a0JM, McCall\u00a0D, O\u2019Dwyer\u00a0PJ, Teitelbaum\u00a0U, Both\u00a0S, Plastaras\u00a0JP (2013) Acute toxicity of proton versus photon chemoradiation therapy for pancreatic adenocarcinoma: a cohort study. Int J Radiat Oncol Biol Phys 87(2):311","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"2106_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.pan.2017.07.191","volume":"17","author":"K Maemura","year":"2017","unstructured":"Maemura\u00a0K, Mataki\u00a0Y, Kurahara\u00a0H, Kawasaki\u00a0Y, Iino\u00a0S, Sakoda\u00a0M, Ueno\u00a0S, Arimura\u00a0T, Higashi\u00a0R, Yoshiura\u00a0T, Shinchi\u00a0H, Natsugoe\u00a0S (2017) Comparison of proton beam radiotherapy and hyper-fractionated accelerated chemoradiotherapy for locally advanced pancreatic cancer. Pancreatology 17(5):833\u2013838","journal-title":"Pancreatology"},{"issue":"43","key":"2106_CR18","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","volume":"24","author":"A McGuigan","year":"2018","unstructured":"McGuigan\u00a0A, Kelly\u00a0P, Turkington\u00a0RC, Jones\u00a0C, Coleman\u00a0HG, McCain\u00a0RS (2018) Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 24(43):4846\u20134861","journal-title":"World J Gastroenterol"},{"issue":"8","key":"2106_CR19","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1245\/s10434-019-07471-z","volume":"26","author":"T Mizumoto","year":"2019","unstructured":"Mizumoto\u00a0T, Terashima\u00a0K, Matsuo\u00a0Y, Nagano\u00a0F, Demizu\u00a0Y, Mima\u00a0M, Sulaiman\u00a0NS, Tokumaru\u00a0S, Okimoto\u00a0T, Toyama\u00a0H, Fukumoto\u00a0T (2019) Proton radiotherapy for isolated local recurrence of primary resected pancreatic ductal Adenocarcinoma. Ann Surg Oncol 26(8):2587\u20132594","journal-title":"Ann Surg Oncol"},{"key":"2106_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.addr.2016.11.006","volume":"109","author":"R Mohan","year":"2017","unstructured":"Mohan\u00a0R, Grosshans\u00a0D (2017) Proton therapy\u2014present and future. Adv Drug Deliv Rev 109:26\u201344","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"2106_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00066-014-0610-8","volume":"190","author":"A Nakamura","year":"2014","unstructured":"Nakamura\u00a0A, Itasaka\u00a0S, Takaori\u00a0K, Kawaguchi\u00a0Y, Shibuya\u00a0K, Yoshimura\u00a0M, Matsuo\u00a0Y, Mizowaki\u00a0T, Uemoto\u00a0S, Hiraoka\u00a0M (2014) Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable prognosis. Strahlenther Onkol 190(5):485\u2013490","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"2106_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/0284186X.2012.762997","volume":"52","author":"RC Nichols","year":"2013","unstructured":"Nichols\u00a0RC, George\u00a0TJ, Zaiden\u00a0RA, Awad\u00a0ZT, Asbun\u00a0HJ, Huh\u00a0S, Ho\u00a0MW, Mendenhall\u00a0NP, Morris\u00a0CG, Hoppe\u00a0BS (2013) Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a\u00a0low incidence of gastrointestinal toxicity. Acta Oncol 52(3):498\u2013505","journal-title":"Acta Oncol"},{"issue":"1","key":"2106_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13014-022-02001-w","volume":"17","author":"Y Ogura","year":"2022","unstructured":"Ogura\u00a0Y, Terashima\u00a0K, Nanno\u00a0Y, Park\u00a0S, Suga\u00a0M, Takahashi\u00a0D, Matsuo\u00a0Y, Sulaiman\u00a0NS, Tokumaru\u00a0S, Okimoto\u00a0T, Toyama\u00a0H, Fukumoto\u00a0T (2022) Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy for non-metastatic locally advanced pancreatic cancer: a\u00a0single-center retrospective study. Radiat Oncol 17(1):32","journal-title":"Radiat Oncol"},{"issue":"8","key":"2106_CR24","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.pan.2018.09.012","volume":"18","author":"D O\u2019Reilly","year":"2018","unstructured":"O\u2019Reilly\u00a0D, Fou\u00a0L, Hasler\u00a0E, Hawkins\u00a0J, O\u2019Connell\u00a0S, Pelone\u00a0F, Callaway\u00a0M, Campbell\u00a0F, Capel\u00a0M, Charnley\u00a0R, Corrie\u00a0P, Elliot\u00a0D, Goodburn\u00a0L, Jewell\u00a0A, Joharchi\u00a0S, McGeeney\u00a0L, Mukherjee\u00a0S, Oppong\u00a0K, Whelan\u00a0P, Primrose\u00a0J, Neoptolemos\u00a0J (2018) Diagnosis and management of pancreatic cancer in adults: a summary of guidelines from the UK National Institute for Health and Care Excellence. Pancreatology 18(8):962\u2013970","journal-title":"Pancreatology"},{"issue":"1","key":"2106_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.21037\/jgo.2019.03.02","volume":"11","author":"MS Rutenberg","year":"2020","unstructured":"Rutenberg\u00a0MS, Nichols\u00a0RC (2020) Proton beam radiotherapy for pancreas cancer. J\u00a0Gastrointest Oncol 11(1):166\u2013175","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"2106_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1245\/s10434-017-6134-6","volume":"25","author":"JF Ryan","year":"2018","unstructured":"Ryan\u00a0JF, Groot\u00a0VP, Rosati\u00a0LM, Hacker-Prietz\u00a0A, Narang\u00a0AK, McNutt\u00a0TR, Jackson\u00a0JF, Le\u00a0DT, Jaffee\u00a0EM, Zheng\u00a0L, Laheru\u00a0DA, He\u00a0J, Pawlik\u00a0TM, Weiss\u00a0MJ, Wolfgang\u00a0CL, Herman\u00a0JM (2018) Stereotactic body radiation therapy for isolated local recurrence after surgical resection of pancreatic ductal adenocarcinoma appears to be safe and effective. Ann Surg Oncol 25(1):280\u2013289","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"2106_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.14338\/IJPT.14-00006.1","volume":"1","author":"S Sachsman","year":"2014","unstructured":"Sachsman\u00a0S, Nichols\u00a0RC, Morris\u00a0CG, Zaiden\u00a0R, Johnson\u00a0EA, Awad\u00a0Z, Bose\u00a0D, Ho\u00a0MW, Huh\u00a0SN, Li\u00a0Z, Kelly\u00a0P, Hoppe\u00a0BS (2014) Proton therapy and concomitant capecitabine for non-metastatic unresectable pancreatic adenocarcinoma. Int J Part Ther 1(3):692\u2013701","journal-title":"Int J Part Ther"},{"issue":"3","key":"2106_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung\u00a0H, Ferlay\u00a0J, Siegel\u00a0RL, Laversanne\u00a0M, Soerjomataram\u00a0I, Jemal\u00a0A, Bray\u00a0F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209\u2013249","journal-title":"Cancer J Clin"},{"issue":"3","key":"2106_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.rcl.2012.03.008","volume":"50","author":"EP Tamm","year":"2012","unstructured":"Tamm\u00a0EP, Balachandran\u00a0A, Bhosale\u00a0PR, Katz\u00a0MH, Fleming\u00a0JB, Lee\u00a0JH, Varadhachary\u00a0GR (2012) Imaging of pancreatic adenocarcinoma: update on staging\/resectability. Radiol Clin North Am 50(3):407\u2013428","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"2106_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.radonc.2011.12.029","volume":"103","author":"K Terashima","year":"2012","unstructured":"Terashima\u00a0K, Demizu\u00a0Y, Hashimoto\u00a0N, Jin\u00a0D, Mima\u00a0M, Fujii\u00a0O, Niwa\u00a0Y, Takatori\u00a0K, Kitajima\u00a0N, Sirakawa\u00a0S, Yonson\u00a0K, Hishikawa\u00a0Y, Abe\u00a0M, Sasaki\u00a0R, Sugimura\u00a0K, Murakami\u00a0M (2012) A phase I\/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Radiother Oncol 103(1):25\u201331","journal-title":"Radiother Oncol"},{"issue":"16","key":"2106_CR31","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1200\/JCO.19.02274","volume":"38","author":"E Versteijne","year":"2020","unstructured":"Versteijne\u00a0E, Suker\u00a0M, Groothuis\u00a0K, Akkermans-Vogelaar\u00a0JM, Besselink\u00a0MG, Bonsing\u00a0BA, Buijsen\u00a0J, Busch\u00a0OR, Creemers\u00a0G\u2011JM, van Dam\u00a0RM, Eskens\u00a0FALM, Festen\u00a0S, de Groot\u00a0JWB, Groot\u00a0Koerkamp B, de Hingh\u00a0IH, Homs\u00a0MYV, van Hooft\u00a0JE, Kerver\u00a0ED, Luelmo\u00a0SAC, Neelis\u00a0KJ, Nuyttens\u00a0J, Paardekooper\u00a0GMRM, Patijn\u00a0GA, van der Sangen\u00a0MJC, de Vos-Geelen\u00a0J, Wilmink\u00a0JW, Zwinderman\u00a0AH, Punt\u00a0CJ, van Eijck\u00a0CH, van Tienhoven\u00a0G (2020) Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase\u00a0III PREOPANC trial. J\u00a0Clin Oncol 38(16):1763\u20131773","journal-title":"J Clin Oncol"},{"issue":"4","key":"2106_CR32","first-page":"343","volume":"4","author":"AT Wild","year":"2013","unstructured":"Wild\u00a0AT, Hiniker\u00a0SM, Chang\u00a0DT, Tran\u00a0PT, Khashab\u00a0MA, Limaye\u00a0MR, Laheru\u00a0DA, Le\u00a0DT, Kumar\u00a0R, Pai\u00a0JS, Hargens\u00a0B, Sharabi\u00a0AB, Shin\u00a0EJ, Zheng\u00a0L, Pawlik\u00a0TM, Wolfgang\u00a0CL, Koong\u00a0AC, Herman\u00a0JM (2013) Re-irradiation with stereotactic body radiation therapy as a\u00a0novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions. J\u00a0Gastrointest Oncol 4(4):343\u2013351","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"2106_CR33","doi-asserted-by":"publisher","first-page":"E208","DOI":"10.1016\/j.ijrobp.2016.06.1114","volume":"96","author":"KD Woodhouse","year":"2016","unstructured":"Woodhouse\u00a0KD, Elrakhawy\u00a0M, Jain\u00a0A, Ben-Josef\u00a0E, Metz\u00a0JM, Plastaras\u00a0JP, Lukens\u00a0JN (2016) Acute toxicity of proton versus photon adjuvant chemoradiation in the treatment of pancreatic cancer: a cohort study. Int J Radiat Oncol Biol Phys 96(2):E208\u2013E209","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"2106_CR34","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.21037\/jgo-21-593","volume":"13","author":"T Rapp","year":"2022","unstructured":"Rapp\u00a0T, Rutenberg\u00a0M, Morris\u00a0C, Nichols\u00a0R (2022) Dose-escalated proton therapy with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable or medically inoperable pancreatic cancer: a\u00a0phase II trial. J\u00a0Gastrointest Oncol 13:1395\u20131401","journal-title":"J Gastrointest Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-023-02106-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T18:03:36Z","timestamp":1698170616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-023-02106-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2106"],"URL":"https:\/\/doi.org\/10.1007\/s00066-023-02106-5","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"2 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.\u00a0Lautenschlaeger, C.\u00a0Dumke, L.\u00a0Exeli, H.\u00a0Hauswald, R.\u00a0Engenhart-Cabillic and F.\u00a0Eberle declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}